Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Moderna recall COVID vaccines after stainless steel contaminants found

September 2, 2021 Medical Communications

Moderna and Takeda Pharmaceutical on Wednesday said they are working with Japanese authorities to recall three batches of their COVID-19 …
News

FDA seeks new warnings on arthritis drugs

September 2, 2021 Medical Communications

The FDA has requested that Pfizer, Eli Lilly, and AbbVie include additional warnings on their arthritis drugs about the risks …
News
andrei_r_-_shutterstock_1935537274_720

NICE and Cochrane to collaborate on living recommendations

September 1, 2021 Medical Communications, Research and Development

NICE has announced a collaboration with Cochrane, in which Cochrane will help deliver ‘living’ recommendations across the NICE guideline portfolio. …
News

Viper venom found to inhibit COVID virus from multiplying

September 1, 2021 Medical Communications, Research and Development

Brazilian researchers have found that a molecule in the venom of a jararacussu pit viper can prevent coronavirus reproduction. The …
News
moderna_norwood_plant

Fourth contaminated Moderna vial found in Japan

September 1, 2021 Medical Communications, Research and Development

A fourth contamination case in less than a week in Japan has been reported involving Moderna’s COVID-19 vaccine, which threatens …
News

Blood-clot risk “substantially higher” from COVID than from jabs

August 27, 2021 Medical Communications

The risks of developing a blood clot are “substantially higher” after catching coronavirus than following a COVID vaccine, research shows. …
News

UCB’s bimekizumab granted marketing authorisation by MHRA for plaque psoriasis

August 27, 2021 Medical Communications

UCB’s bimekizumab has been granted marketing authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA)  for the treatment of …
News

NICE rejects combination treatment for multiple myeloma

August 27, 2021 Medical Communications

NICE does not recommend daratumumab (Darzalex, Janssen Cilag), plus bortezomib, thalidomide and dexamethasone, as a treatment option for untreated multiple …
News
artificial_heart

CARMAT’s artificial heart commercially implanted successfully for third time

August 27, 2021 Medical Communications

CARMAT’s artificial heart, Aeson, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, has been …
News

New PPE mask range can begin to kill SARS-CoV-2 on contact

August 27, 2021 Medical Communications

A new PPE mask range has been launched that can begin to kill SARS-CoV-2 and other viruses and pathogens on …
News

Malaria sickness could be cut by 70%, study finds

August 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have found a new approach to protecting young African …
News
mark

Stelis Biopharma appoints Mark Womack as new CEO

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Stelis Biopharma Limited has announced the appointment of Mark W Womack as the new Chief Executive Officer.Womack is also the …
Appointment

PureTech appoints Julie Krop as Chief Medical Officer

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical-stage biotherapeutics company PureTech has appointed Julie Krop as Chief Medical Officer.Krop will oversee all clinical development, Regulatory, CMC, and …
Appointment

Tracey Lodie appointed Chief Scientific Officer of Quell Therapeutics

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Quell Therapeutics has announced the appointment of Tracey Lodie as Chief Scientific Officer.Dr Lodie brings to Quell more than 20 …
Appointment
anita_cooper_002

RareCan appoints Dr Anita Cooper as Non-Executive Director

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Cancer research company RareCan has appointed Dr Anita Cooper as Non-Executive Director.Cooper has over 30 years’ experience in global business …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025